Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis (Q53852476)
Jump to navigation
Jump to search
scientific article published on September 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis |
scientific article published on September 1, 2003 |
Statements
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis (English)
Anjuli Nayak
Thomas Casale
John Condemi
Margaret McAlary
Angel Fowler-Taylor
Giovanni Della Cioppa
Niroo Gupta
1 September 2003
24
5
323-329